
Discovery of a 3-(4-Pyrimidinyl) Indazole (MLi-2), an Orally Available and Selective Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitor that Reduces Brain Kinase Activity
Scott, Jack D., DeMong, Duane E., Greshock, Thomas J., Basu, Kallol, Dai, Xing, Harris, Joel, Hruza, Alan, Li, Sarah W., Lin, Sue-Ing, Liu, Hong, Macala, Megan K., Hu, Zhiyong, Mei, Hong, Zhang, HonglVolume:
60
Langue:
english
Journal:
Journal of Medicinal Chemistry
DOI:
10.1021/acs.jmedchem.7b00045
Date:
April, 2017
Fichier:
PDF, 675 KB
english, 2017